-
1
-
-
0022495870
-
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone
-
Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
-
(1986)
J. Virol.
, vol.59
, pp. 284-291
-
-
Adachi, A.1
Gendelman, H.E.2
Koenig, S.3
Folks, T.4
Willey, R.5
Rabson, A.6
Martin, M.A.7
-
2
-
-
0030835321
-
Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A
-
Aiken, C. 1997. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71:5871-5877.
-
(1997)
J. Virol.
, vol.71
, pp. 5871-5877
-
-
Aiken, C.1
-
3
-
-
0027049212
-
Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines
-
Arthur, L. O., J. W. Bess, Jr., R. C. Sowder, 2nd, R. E. Benveniste, D. L. Mann, J. C. Chermann, and L. E. Henderson. 1992. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258:1935-1938.
-
(1992)
Science
, vol.258
, pp. 1935-1938
-
-
Arthur, L.O.1
Bess Jr., J.W.2
Sowder II, R.C.3
Benveniste, R.E.4
Mann, D.L.5
Chermann, J.C.6
Henderson, L.E.7
-
4
-
-
0032488846
-
The proteasome: Paradigm of a self-compartmentalizing protease
-
Baumeister, W., J. Walz, F. Zuhl, and E. Seemuller. 1998. The proteasome: paradigm of a self-compartmentalizing protease. Cell 92:367-380.
-
(1998)
Cell
, vol.92
, pp. 367-380
-
-
Baumeister, W.1
Walz, J.2
Zuhl, F.3
Seemuller, E.4
-
5
-
-
2442707757
-
Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity
-
Campbell, E. M., R. Nunez, and T. J. Hope. 2004. Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity. J. Virol. 78:5745-5755.
-
(2004)
J. Virol.
, vol.78
, pp. 5745-5755
-
-
Campbell, E.M.1
Nunez, R.2
Hope, T.J.3
-
6
-
-
0036844376
-
A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes
-
Cavrois, M., C. De Noronha, and W. C. Greene. 2002. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 20:1151-1154.
-
(2002)
Nat. Biotechnol.
, vol.20
, pp. 1151-1154
-
-
Cavrois, M.1
De Noronha, C.2
Greene, W.C.3
-
7
-
-
0027270147
-
The origin of HIV-1 isolate HTLV-IIIB
-
Chang, S. Y., B. H. Bowman, J. B. Weiss, R. E. Garcia, and T. J. White. 1993. The origin of HIV-1 isolate HTLV-IIIB. Nature 383:466-469.
-
(1993)
Nature
, vol.383
, pp. 466-469
-
-
Chang, S.Y.1
Bowman, B.H.2
Weiss, J.B.3
Garcia, R.E.4
White, T.J.5
-
8
-
-
0027965903
-
HIV-1 reverse transcription. A termination step at the center of the genome
-
Charneau, P., G. Mirambeau, P. Roux, S. Paulous, H. Buc, and F. Clavel. 1994. HIV-1 reverse transcription. A termination step at the center of the genome. J. Mol. Biol. 241:651-662.
-
(1994)
J. Mol. Biol.
, vol.241
, pp. 651-662
-
-
Charneau, P.1
Mirambeau, G.2
Roux, P.3
Paulous, S.4
Buc, H.5
Clavel, F.6
-
9
-
-
0023681241
-
Distinct biological and serological properties of human immunodeficiency viruses from the brain
-
Cheng-Mayer, C., and J. A. Levy. 1988. Distinct biological and serological properties of human immunodeficiency viruses from the brain. Ann. Neurol. 23(Suppl.):S58-S61.
-
(1988)
Ann. Neurol.
, vol.23
, Issue.SUPPL.
-
-
Cheng-Mayer, C.1
Levy, J.A.2
-
10
-
-
0023761449
-
Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity
-
Chesebro, B., and K. Wehrly. 1988. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J. Virol. 62:3779-3788.
-
(1988)
J. Virol.
, vol.62
, pp. 3779-3788
-
-
Chesebro, B.1
Wehrly, K.2
-
11
-
-
0030016595
-
Structure and functions of the 20S and 26S proteasomes
-
Coux, O., K. Tanaka, and A. L. Goldberg. 1996. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:801-847.
-
(1996)
Annu. Rev. Biochem.
, vol.65
, pp. 801-847
-
-
Coux, O.1
Tanaka, K.2
Goldberg, A.L.3
-
12
-
-
0037154214
-
Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function
-
Demirov, D. G., A. Ono, J. M. Orenstein, and E. O. Freed. 2002. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc. Natl. Acad. Sci. USA 99:955-960.
-
(2002)
Proc. Natl. Acad. Sci. USA
, vol.99
, pp. 955-960
-
-
Demirov, D.G.1
Ono, A.2
Orenstein, J.M.3
Freed, E.O.4
-
14
-
-
0040117958
-
Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases
-
Drose, S., and K. Altendorf. 1997. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J. Exp. Biol. 200:1-8.
-
(1997)
J. Exp. Biol.
, vol.200
, pp. 1-8
-
-
Drose, S.1
Altendorf, K.2
-
15
-
-
0035736099
-
The proteasome: A new target for novel drug therapies
-
Elliott, P. J., and J. S. Ross. 2001. The proteasome: a new target for novel drug therapies. Am. J. Clin. Pathol. 116:637-646.
-
(2001)
Am. J. Clin. Pathol.
, vol.116
, pp. 637-646
-
-
Elliott, P.J.1
Ross, J.S.2
-
16
-
-
0034710564
-
Endocytic entry of HIV-1
-
Fackler, O. T., and B. M. Peterlin. 2000. Endocytic entry of HIV-1. Curr. Biol. 10:1005-1008.
-
(2000)
Curr. Biol.
, vol.10
, pp. 1005-1008
-
-
Fackler, O.T.1
Peterlin, B.M.2
-
17
-
-
0030002637
-
HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
-
Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
-
(1996)
Science
, vol.272
, pp. 872-877
-
-
Feng, Y.1
Broder, C.C.2
Kennedy, P.E.3
Berger, E.A.4
-
18
-
-
0029033981
-
Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin
-
Fenteany, G., R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726-731.
-
(1995)
Science
, vol.268
, pp. 726-731
-
-
Fenteany, G.1
Standaert, R.F.2
Lane, W.S.3
Choi, S.4
Corey, E.J.5
Schreiber, S.L.6
-
19
-
-
0035037512
-
Managing influenza: Amantadine, rimantadine and beyond
-
Fleming, D. M. 2001. Managing influenza: amantadine, rimantadine and beyond. Int. J. Clin. Pract. 55:189-195.
-
(2001)
Int. J. Clin. Pract.
, vol.55
, pp. 189-195
-
-
Fleming, D.M.1
-
20
-
-
0036827862
-
Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus
-
Fredericksen, B. L., B. L. Wei, J. Yao, T. Luo, and J. V. Garcia. 2002. Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus. J. Virol. 76:11440-11446.
-
(2002)
J. Virol.
, vol.76
, pp. 11440-11446
-
-
Fredericksen, B.L.1
Wei, B.L.2
Yao, J.3
Luo, T.4
Garcia, J.V.5
-
21
-
-
0023816112
-
Entry of human immunodeficiency virus (HIV) into MT-2, human T cell leukemia virus carrier cell line
-
Goto, T., S. Harada, N. Yamamoto, and M. Nakai. 1988. Entry of human immunodeficiency virus (HIV) into MT-2, human T cell leukemia virus carrier cell line. Arch. Virol. 102:29-38.
-
(1988)
Arch. Virol.
, vol.102
, pp. 29-38
-
-
Goto, T.1
Harada, S.2
Yamamoto, N.3
Nakai, M.4
-
23
-
-
0034120373
-
Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers
-
Hendrix, C. W., C. Flexner, R. T. MacFarland, C. Giandomenico, E. J. Fuchs, E. Redpath, G. Bridger, and G. W. Henson. 2000. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob. Agents Chemother. 44:1667-1673.
-
(2000)
Antimicrob. Agents Chemother.
, vol.44
, pp. 1667-1673
-
-
Hendrix, C.W.1
Flexner, C.2
MacFarland, R.T.3
Giandomenico, C.4
Fuchs, E.J.5
Redpath, E.6
Bridger, G.7
Henson, G.W.8
-
24
-
-
0029770079
-
Virus-cell and cell-cell fusion
-
Hernandez, L. D., L. R. Hoffman, T. G. Wolfsberg, and J. M. White. 1996. Virus-cell and cell-cell fusion. Annu. Rev. Cell Dev. Biol. 12:627-661.
-
(1996)
Annu. Rev. Cell Dev. Biol.
, vol.12
, pp. 627-661
-
-
Hernandez, L.D.1
Hoffman, L.R.2
Wolfsberg, T.G.3
White, J.M.4
-
25
-
-
0026562720
-
Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene
-
Kimpton, J., and M. Emerman. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66:2232-2239.
-
(1992)
J. Virol.
, vol.66
, pp. 2232-2239
-
-
Kimpton, J.1
Emerman, M.2
-
26
-
-
0023214674
-
Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms
-
Koyanagi, Y., S. Miles, R. T. Mitsuyasu, J. E. Merrill, H. V. Vinters, and I. S. Chen. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822.
-
(1987)
Science
, vol.236
, pp. 819-822
-
-
Koyanagi, Y.1
Miles, S.2
Mitsuyasu, R.T.3
Merrill, J.E.4
Vinters, H.V.5
Chen, I.S.6
-
27
-
-
0025815375
-
Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of replication-competent and -defective viral genomes
-
Li, Y., J. C. Kappes, J. A. Conway, R. W. Price, G. M. Shaw, and B. H. Hahn. 1991. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J. Virol. 65:3973-3985.
-
(1991)
J. Virol.
, vol.65
, pp. 3973-3985
-
-
Li, Y.1
Kappes, J.C.2
Conway, J.A.3
Price, R.W.4
Shaw, G.M.5
Hahn, B.H.6
-
28
-
-
0032520144
-
Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: Implications for HIV-based gene transfer systems
-
Luo, T., J. L. Douglas, R. L. Livingston, and J. V. Garcia. 1998. Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: implications for HIV-based gene transfer systems. Virology 241:224-233.
-
(1998)
Virology
, vol.241
, pp. 224-233
-
-
Luo, T.1
Douglas, J.L.2
Livingston, R.L.3
Garcia, J.V.4
-
29
-
-
0019976569
-
Pathway of vesicular stomatitis virus entry leading to infection
-
Matlin, K. S., H. Reggio, A. Helenius, and K. Simons. 1982. Pathway of vesicular stomatitis virus entry leading to infection. J. Mol. Biol. 156:609-631.
-
(1982)
J. Mol. Biol.
, vol.156
, pp. 609-631
-
-
Matlin, K.S.1
Reggio, H.2
Helenius, A.3
Simons, K.4
-
30
-
-
0031900144
-
Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus
-
Ott, D. E., L. V. Coren, T. D. Copeland, B. P. Kane, D. G. Johnson, R. C. Sowder, 2nd, Y. Yoshinaka, S. Oroszlan, L. O. Arthur, and L. E. Henderson. 1998. Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus. J. Virol. 72:2962-2968.
-
(1998)
J. Virol.
, vol.72
, pp. 2962-2968
-
-
Ott, D.E.1
Coren, L.V.2
Copeland, T.D.3
Kane, B.P.4
Johnson, D.G.5
Sowder II, R.C.6
Yoshinaka, Y.7
Oroszlan, S.8
Arthur, L.O.9
Henderson, L.E.10
-
31
-
-
0027980321
-
The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B
-
Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78:773-785.
-
(1994)
Cell
, vol.78
, pp. 773-785
-
-
Palombella, V.J.1
Rando, O.J.2
Goldberg, A.L.3
Maniatis, T.4
-
32
-
-
0034700146
-
Ubiquitin is part of the retrovirus budding machinery
-
Patnaik, A., V. Chau, and J. W. Wills. 2000. Ubiquitin is part of the retrovirus budding machinery. Proc. Natl. Acad. Sci. USA 97:13069-13074.
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 13069-13074
-
-
Patnaik, A.1
Chau, V.2
Wills, J.W.3
-
33
-
-
0023765764
-
Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis
-
Pauza, C. D., and T. M. Price. 1988. Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis. J. Cell Biol. 107:959-968.
-
(1988)
J. Cell Biol.
, vol.107
, pp. 959-968
-
-
Pauza, C.D.1
Price, T.M.2
-
34
-
-
0026318224
-
Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI
-
Peden, K., M. Emerman, and L. Montagnier. 1991. Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology 185: 661-672.
-
(1991)
Virology
, vol.185
, pp. 661-672
-
-
Peden, K.1
Emerman, M.2
Montagnier, L.3
-
35
-
-
0028068526
-
Involvement of the vacuolar H(+)-ATPase in animal virus entry
-
Perez, L., and L. Carrasco. 1994. Involvement of the vacuolar H(+)-ATPase in animal virus entry. J. Gen. Virol. 75:2595-2606.
-
(1994)
J. Gen. Virol.
, vol.75
, pp. 2595-2606
-
-
Perez, L.1
Carrasco, L.2
-
36
-
-
0037192550
-
The human 26S proteasome is a target of antiretroviral agents
-
Piccinini, M., M. T. Rinaudo, N. Chiapello, E. Ricotti, S. Baldovino, M. Mostert, and P. A. Tovo. 2002. The human 26S proteasome is a target of antiretroviral agents. AIDS 16:693-700.
-
(2002)
AIDS
, vol.16
, pp. 693-700
-
-
Piccinini, M.1
Rinaudo, M.T.2
Chiapello, N.3
Ricotti, E.4
Baldovino, S.5
Mostert, M.6
Tovo, P.A.7
-
37
-
-
0021912920
-
Complete nucleotide sequence of the AIDS virus, HTLV-III
-
Ratner, L., W. Haseltine, R. Patarca, K. J. Livak, B. Starcich, S. F. Josephs, E. R. Doran, J. A. Rafalski, E. A. Whitehorn, K. Baumeister, L. Ivanoff, S. R. J. Petteway, M. L. Pearsons, J. A. Lautenberg, T. S. Papas, J. Ghrayeb, N. T. Chang, R. C. Gallo, and F. Wong-Staal. 1985. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313:277-284.
-
(1985)
Nature
, vol.313
, pp. 277-284
-
-
Ratner, L.1
Haseltine, W.2
Patarca, R.3
Livak, K.J.4
Starcich, B.5
Josephs, S.F.6
Doran, E.R.7
Rafalski, J.A.8
Whitehorn, E.A.9
Baumeister, K.10
Ivanoff, L.11
Petteway, S.R.J.12
Pearsons, M.L.13
Lautenberg, J.A.14
Papas, T.S.15
Ghrayeb, J.16
Chang, N.T.17
Gallo, R.C.18
Wong-Staal, F.19
-
38
-
-
0037059049
-
Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics
-
Reeves, J. D., S. A. Gallo, N. Ahmad, J. L. Miamidian, P. E. Harvey, M. Sharron, S. Pohlmann, J. N. Sfakianos, C. A. Derdeyn, R. Blumenthal, E. Hunter, and R. W. Doms. 2002. Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics. Proc. Natl. Acad. Sci. USA 99:16249-16254.
-
(2002)
Proc. Natl. Acad. Sci. USA
, vol.99
, pp. 16249-16254
-
-
Reeves, J.D.1
Gallo, S.A.2
Ahmad, N.3
Miamidian, J.L.4
Harvey, P.E.5
Sharron, M.6
Pohlmann, S.7
Sfakianos, J.N.8
Derdeyn, C.A.9
Blumenthal, R.10
Hunter, E.11
Doms, R.W.12
-
39
-
-
2342514225
-
Impact of mutations in the coreceptor binding site on human immunodeficiency virus type 1 fusion, infection, and entry inhibitor sensitivity
-
Reeves, J. D., J. L. Miamidian, M. J. Biscone, F. H. Lee, N. Ahmad, T. C. Pierson, and R. W. Doms. 2004. Impact of mutations in the coreceptor binding site on human immunodeficiency virus type 1 fusion, infection, and entry inhibitor sensitivity. J. Virol. 78:5476-5485.
-
(2004)
J. Virol.
, vol.78
, pp. 5476-5485
-
-
Reeves, J.D.1
Miamidian, J.L.2
Biscone, M.J.3
Lee, F.H.4
Ahmad, N.5
Pierson, T.C.6
Doms, R.W.7
-
40
-
-
0021914933
-
Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2)
-
Sanchez-Pescador, R., M. D. Power, P. J. Barr, K. S. Steimer, M. M. Stempien, S. L. Brown-Shimer, W. W. Gee, A. Renard, A. Randolph, J. A. Levy, D. Dina, and P. A. Luciw. 1985. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science 227:484-492.
-
(1985)
Science
, vol.227
, pp. 484-492
-
-
Sanchez-Pescador, R.1
Power, M.D.2
Barr, P.J.3
Steimer, K.S.4
Stempien, M.M.5
Brown-Shimer, S.L.6
Gee, W.W.7
Renard, A.8
Randolph, A.9
Levy, J.A.10
Dina, D.11
Luciw, P.A.12
-
41
-
-
0347003570
-
Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes
-
Schaeffer, E., V. B. Soros, and W. C. Greene. 2004. Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes. J. Virol. 78:1375-1383.
-
(2004)
J. Virol.
, vol.78
, pp. 1375-1383
-
-
Schaeffer, E.1
Soros, V.B.2
Greene, W.C.3
-
42
-
-
0034700088
-
Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2
-
Schubert, U., D. E. Ott, E. N. Chertova, R. Welker, U. Tessmer, M. F. Princiotta, J. R. Bennink, H. G. Krausslich, and J. W. Yewdell. 2000. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc. Natl. Acad. Sci. USA 97:13057-13062.
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 13057-13062
-
-
Schubert, U.1
Ott, D.E.2
Chertova, E.N.3
Welker, R.4
Tessmer, U.5
Princiotta, M.F.6
Bennink, J.R.7
Krausslich, H.G.8
Yewdell, J.W.9
-
43
-
-
2642670312
-
Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1
-
Schwartz, O., V. Marechal, B. Friguet, F. Arenzana-Seisdedos, and J. M. Heard. 1998. Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. J. Virol. 72:3845-3850.
-
(1998)
J. Virol.
, vol.72
, pp. 3845-3850
-
-
Schwartz, O.1
Marechal, V.2
Friguet, B.3
Arenzana-Seisdedos, F.4
Heard, J.M.5
-
44
-
-
0034700097
-
A role for ubiquitin ligase recruitment in retrovirus release
-
Strack, B., A. Calistri, M. A. Accola, G. Palu, and H. G. Gottlinger. 2000. A role for ubiquitin ligase recruitment in retrovirus release. Proc. Natl. Acad. Sci. USA 97:13063-13068.
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 13063-13068
-
-
Strack, B.1
Calistri, A.2
Accola, M.A.3
Palu, G.4
Gottlinger, H.G.5
-
45
-
-
0022005974
-
Nucleotide sequence of the AIDS virus, LAV
-
Wain-Hobson, S., P. Sonigo, O. Danes, S. Cole, and M. Alizon. 1985. Nucleotide sequence of the AIDS virus, LAV. Cell 40:9-17.
-
(1985)
Cell
, vol.40
, pp. 9-17
-
-
Wain-Hobson, S.1
Sonigo, P.2
Danes, O.3
Cole, S.4
Alizon, M.5
-
46
-
-
0027959493
-
Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection
-
Wild, C. T., D. C. Shugars, T. K. Greenwell, C. B. McDanal, and T. J. Matthews. 1994. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 91:9770-9774.
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 9770-9774
-
-
Wild, C.T.1
Shugars, D.C.2
Greenwell, T.K.3
McDanal, C.B.4
Matthews, T.J.5
|